Report cover image

France Invasive Neurostimulation Devices Market to 2033

Published Aug 07, 2026
Length 135 Pages
SKU # BMKS21565543

Description

The invasive neurostimulation devices market in France is driven by the country’s well-established neurological healthcare infrastructure, advanced neurosurgical capabilities, and growing adoption of sophisticated device-based treatments for complex neurological conditions. Deep brain stimulation (DBS), spinal cord stimulation (SCS), and other implantable neurostimulation technologies are becoming increasingly incorporated into clinical care pathways for disorders including Parkinson’s disease, epilepsy, chronic pain, and movement disorders. French university hospitals and specialized neuroscience institutions continue to build expertise in invasive neuromodulation procedures, contributing to broader clinical acceptance of these technologies. Partnerships among hospitals, research organizations, and medical device manufacturers also support the assessment of emerging stimulation techniques and implantable systems. France’s regulatory environment further encourages the application of evidence-based neurostimulation therapies, promoting the adoption of treatments that demonstrate measurable improvements in patient outcomes and sustained clinical benefits.

Ongoing clinical research is further increasing confidence in invasive neurostimulation therapies throughout France. In December 2024, a French clinical epilepsy study conducted at AP-HP Timone Hospital in Marseille reported that patients with focal drug-resistant epilepsy who received medial pulvinar deep brain stimulation experienced a significant decrease in seizure frequency during 12 months of follow-up. The results indicated a sustained therapeutic response among implanted patients within an INSERM-affiliated neurostimulation research framework. These findings reinforce interest in extending neurostimulation applications beyond conventional treatment indications. Continued clinical evidence, growing expertise in implantable technologies, and the incorporation of research outcomes into everyday clinical practice are expected to strengthen the position of invasive neurostimulation devices within France’s neurological care landscape.

Table of Contents

135 Pages
1. Introduction
1.1 Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
3.2.1 Data Triangulation and Validation:
4. France Invasive Neurostimulation Devices Market Landscape
4.1 Overview
4.2 Ecosystem Analysis
4.2.1 List of Vendors in the Value Chain
5. Invasive Neurostimulation Devices Market Key Market Dynamics
5.1 Invasive Neurostimulation Devices Market – Key Market Dynamics
5.2 Market Drivers
5.3 Market Restraints
5.4 Market Opportunities
5.5 Future Trends
5.6 Impact of Drivers and Restraints
6. France Invasive Neurostimulation Devices Market – Analysis
6.1 France Invasive Neurostimulation Devices Market Revenue (US$ Million), 2022–2033
6.2 France Invasive Neurostimulation Devices Market Revenue and Forecast Analysis
7. France Invasive Neurostimulation Devices Market Analysis – by Product Type
7.1 France Invasive Neurostimulation Devices Market – Revenue and Forecast, 2022–2033 (US$ Million) – by Product Type
8. France Invasive Neurostimulation Devices Market Analysis – by Application
8.1 France Invasive Neurostimulation Devices Market – Revenue and Forecast, 2022–2033 (US$ Million) – by Application
9. France Invasive Neurostimulation Devices Market Analysis – by End User
9.1 France Invasive Neurostimulation Devices Market – Revenue and Forecast, 2022–2033 (US$ Million) – by End User
10. Competitive Landscape
10.1 Heat Map Analysis by Key Players
10.1 Company Positioning and Concentration
11. Industry Landscape
11.1 Overview
11.2 Market Initiative
11.2 Partnerships and Collaborations
11.2 Other Developments
12. Company Profiles
12.1 Medtronic Plc
12.1. 1 Key Facts
12.1. 2 Business Description
12.1. 3 Products and Services
12.1. 4 Financial Overview
12.1. 5 SWOT Analysis
12.1. 6 Key Developments
12.2 Abbott Laboratories
12.2. 1 Key Facts
12.2. 2 Business Description
12.2. 3 Products and Services
12.2. 4 Financial Overview
12.2. 5 SWOT Analysis
12.2. 6 Key Developments
12.3 Boston Scientific Corporation
12.3. 1 Key Facts
12.3. 2 Business Description
12.3. 3 Products and Services
12.3. 4 Financial Overview
12.3. 5 SWOT Analysis
12.3. 6 Key Developments
12.4 LivaNova Plc
12.4. 1 Key Facts
12.4. 2 Business Description
12.4. 3 Products and Services
12.4. 4 Financial Overview
12.4. 5 SWOT Analysis
12.4. 6 Key Developments
12.5 Nevro Corp
12.5. 1 Key Facts
12.5. 2 Business Description
12.5. 3 Products and Services
12.5. 4 Financial Overview
12.5. 5 SWOT Analysis
12.5. 6 Key Developments
12.6 NeuroPace Inc
12.6. 1 Key Facts
12.6. 2 Business Description
12.6. 3 Products and Services
12.6. 4 Financial Overview
12.6. 5 SWOT Analysis
12.6. 6 Key Developments
12.7 Newronika SpA
12.7. 1 Key Facts
12.7. 2 Business Description
12.7. 3 Products and Services
12.7. 4 Financial Overview
12.7. 5 SWOT Analysis
12.7. 6 Key Developments
12.8 Saluda Medical Pty Ltd.
12.8. 1 Key Facts
12.8. 2 Business Description
12.8. 3 Products and Services
12.8. 4 Financial Overview
12.8. 5 SWOT Analysis
12.8. 6 Key Developments
12.9 Biotronik SE & Co KG
12.9. 1 Key Facts
12.9. 2 Business Description
12.9. 3 Products and Services
12.9. 4 Financial Overview
12.9. 5 SWOT Analysis
12.9. 6 Key Developments
12.10 Mainstay Medical
12.10. 1 Key Facts
12.10. 2 Business Description
12.10. 3 Products and Services
12.10. 4 Financial Overview
12.10. 5 SWOT Analysis
12.10. 6 Key Developments
13. Appendix
13.1 About Business Market Insights
13.2 List of Abbreviations
TABLE OF TABLES
Table 1. France Invasive Neurostimulation Devices Market Segmentation
Table 2. List of Vendors
Table 3. France Invasive Neurostimulation Devices Market – Revenue, 2022–2025 (US$ Million)
Table 4. France Invasive Neurostimulation Devices Market – Revenue Forecast, 2026–2033 (US$ Million)
Table 5. France Invasive Neurostimulation Devices Market – Revenue, 2022–2025 (US$ Million) – by Product Type
Table 6. France Invasive Neurostimulation Devices Market – Revenue Forecast, 2026–2033 (US$ Million) – by Product Type
Table 7. France Invasive Neurostimulation Devices Market – Revenue, 2022–2025 (US$ Million) – by Application
Table 8. France Invasive Neurostimulation Devices Market – Revenue Forecast, 2026–2033 (US$ Million) – by Application
Table 9. France Invasive Neurostimulation Devices Market – Revenue, 2022–2025 (US$ Million) – by End User
Table 10. France Invasive Neurostimulation Devices Market – Revenue Forecast, 2026–2033 (US$ Million) – by End User
Table 11. List of Abbreviations
TABLE OF FIGURES
Figure 1. Impact Analysis of Drivers and Restraints
Figure 2. France Invasive Neurostimulation Devices Market Revenue, (US$ Million), 2022–2033
Figure 3. Heat Map Analysis by Key Players
Figure 4. Company Positioning and Concentration

Search Inside Report

How Do Licenses Work?
Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.